ImmuCell Corp Files 8-K on Operations and Financials
Ticker: ICCC · Form: 8-K · Filed: Apr 8, 2025 · CIK: 811641
| Field | Detail |
|---|---|
| Company | Immucell Corp /De/ (ICCC) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, operations
Related Tickers: ICEL
TL;DR
ImmuCell filed an 8-K on April 8, 2025, detailing operational and financial updates.
AI Summary
On April 8, 2025, ImmuCell Corporation filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the excerpt.
Why It Matters
This filing indicates ImmuCell Corporation is providing updates on its financial performance and operational status to the SEC, which is important for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting routine operational and financial information, not indicating any immediate or significant risks.
Key Players & Entities
- ImmuCell Corporation (company) — Registrant
- April 08, 2025 (date) — Date of earliest event reported
- Portland, Maine (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by ImmuCell Corporation?
The primary purpose of this 8-K filing is to report on ImmuCell Corporation's Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on April 8, 2025.
What is ImmuCell Corporation's principal executive office address?
ImmuCell Corporation's principal executive office is located at 56 Evergreen Drive, Portland, Maine 04103.
What is ImmuCell Corporation's telephone number?
ImmuCell Corporation's telephone number, including area code, is 207-878-2770.
What is the Commission File Number for ImmuCell Corporation?
The Commission File Number for ImmuCell Corporation is 001-12934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding IMMUCELL CORP /DE/ (ICCC).